$GSK $ANAB Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer - GSK says Jemperli monotherapy could help eligible patients avoid chemotherapy, radiation and surgery. stocktitan.net/news/GSK/jemp…

$HON Honeywell Aerospace forecast shows business aviation growth, expanding fleets and strong utilization continuing through 2035 - Honeywell Aerospace published its annual business aviation outlook, forecasting approximately 14,000 business aircraft deliveries from 2026 through 2035. - The forecast includes 9,950 business jets and 4,200 turboprops, with coverage expanded this year to include turboprops and personal jets. - The company projects the global fleet will grow approximately 29%, from about 39,400 aircraft in 2025 to nearly 51,000 in 2035, while flight hours increase approximately 34% over the same period. - Annual deliveries are expected to rise from approximately 1,280 aircraft in 2026 to more than 1,500 by 2035, with annual delivery value exceeding $37 billion by the end of the forecast period. - Survey findings show 9 of 10 operators expect to fly the same or more hours in 2027 than in 2026. stocktitan.net/news/HON/hone…

$ELVN -HC Wainwright raises Enliven Therapeutics target to $73 from $65 Buy - $EMR -Morgan Stanley raises Emerson Electric target to $145 from $135 Underweight - $ENLT -JPMorgan lowers Enlighten Renewable Energy target to $65 from $80 Underweight - $ENPH -JPMorgan lowers Enphase Energy target to $35 from $40 Neutral

$EL -Jefferies raises Estee Lauder target to $120 from $100 Hold -JPMorgan raises target to $115 from $112 Overweight - $ELF -Jefferies raises e.l.f. Beauty target to $132 from $100 Buy -JPMorgan raises target to $130 from $106 Overweight

$EARN -Piper Sandler lowers Ellington Credit target to $4.50 from $5 Overweight - $EAT -Citi lowers Brinker target to $270 from $282 Buy - $EFX -Mizuho lowers Equifax target to $185 from $210 Outperform

$DKNG -Morgan Stanley lowers DraftKings target to $31 from $36 Overweight -Wells Fargo raises target to $30 from $29 Overweight - $DOC -Wells Fargo lowers Healthpeak Properties target to $19 from $22 = Weight - $DX -Jones Trading lowers Dynex Capital target to $12.50 from $14.75 Buy

$CRH -Barclays lowers CRH target to $110 from $131 Overweight - $DDOG -Bernstein upgrades Datadog to Outperform from Market Perform Raises target to $350 from $237 - $DFTX -RBC reiterates Definium Therapeutics $66 target Outperform -

$CMC -Morgan Stanley lowers Commercial Metals target to $84 from $88 Overweight -BMO lowers target to $73 from $75 Market Perform - $CMCSA -Rosenblatt reiterates Comcast $31 target Buy - $CNK -B. Riley raises Cinemark target to $42 from $37 Neutral

$CRWV -Cantor reiterates CoreWeave $176 target Overweight -Wells Fargo maintains $160 target Overweight -BNP Paribas lowers target to $117 from $169 Outperform -Goldman lowers target to $106 from $139 Upgrades to Buy from Neutral -MoffettNathanson lowers target to $89 from $107 Neutral

$CAI -Canaccord raises Caris Life Sciences target to $30 from $22 Neutral - $CDNA -Canaccord raises CareDx target to $80 from $86 Buy - $CG -Piper Sandler lowers Carlyle Group target to $48 from $54 Overweight - $CHDN -Wells Fargo raises Churchill Downs target to $120 from $117 Overweight

$BYD -Wells Fargo lowers Boyd Gaming target to $86 from $87 = Weight -Morgan Stanley lowers target to $83 from $89 Upgrades to Overweight from = Weight -Susquehanna lowers target to $83 from $87 Upgrades to Positive from Neutral

$BMI -Stifel lowers Badger Meter target to $150 from $165 Buy - $BX -Piper Sander lowers Blackstone target to $125 from $130 Neutral - $BXP -Piper Sandler downgrades BXP to Neutral from Overweight Lowers target to $64 from $72

$AZUL -Goldman initiates Azul coverage at Neutral Sets $8.10 target - $BBIO -Piper Sandler raises BridgeBio Pharma target to $120 from $115 Overweight -Citi lowers target to $91 from $94 Neutral - $BKR -Citi lowers Baker Hughes target to $72 from $75 Buy

$APO -Piper Sandler lowers Apollo Global Management target to $145 from $159 Overweight - $APP -Citi lowers AppLovin target to $500 from $600 Buy - $ARQT -Guggenheim raises Arcutis Biotherapeutics target to $44 from $38 Buy - $AVAV -Citizens JMP lowers AeroVironment target to $170 from $230 Market Outperform

$AMD -Cowen reiterates Advanced Micro Devices $675 target Buy - $AMZN -Morgan Stanley raises Amazon target to $350 from $335 Overweight -Yorkville Ives initiates coverage at Outperform Sets $300 target - $ANRO -HC Wainwright raises Alto Neuroscience target to $60 from $55 Buy

$AEE -Barclays lowers Ameren target to $109 from $117 = Weight - $AEM -Barclays raises Agnico Eagle Mines target to $218 from $188 Overweight - $AGCO -Barclays lowers AGCO target to $97 from $105 Underweight - $AMC B. Riley raises AMC Entertainment target to $3.25 from $2.50 Neutral

$AARD -HC Wainwright Aardvark Therapeutics lowers target to $4 from $6 Neutral - $ACAD -Needham reiterates ACADIA Pharmaceuticals $35 target Buy - $ADAG -HC Wainwright maintains Adagene $7 target Buy - $ADNT -Stifel lowers Adient target to $21 from $26 Buy

$NFLX Netflix earnings outlook: tone and guidance matter more than the beat - Options imply a swing of about 7.3% either way investing.com/news/stock-mar…

$RAMP LiveRamp stock rises as FTC clears Publicis acquisition - The FTC's complaint raised concerns that Publicis's acquisition of LiveRamp, which provides data connectivity services for digital advertising, would harm competition in markets for media agency services and audience data services investing.com/news/stock-mar…

$AERO Aeromexico eyes US expansion after Washington lifts flight curbs - Aeromexico has aircraft available to support growth, helped by leases negotiated during its Chapter 11 restructuring that left it with rates below current market levels investing.com/news/stock-mar…